CRV431 75mg
HEPA-CRV431-201
Phase 2 small_molecule completed
Quick answer
CRV431 75mg for NASH - Nonalcoholic Steatohepatitis is a Phase 2 program (small_molecule) at Hepion Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hepion Pharmaceuticals
- Indication
- NASH - Nonalcoholic Steatohepatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed